Acute Coronary Syndromes

Acute coronary syndrome (ACS) is most commonly caused by a heart attack (myocardial infarction) where blood flow to the heart is suddenly blocked. This is usually caused by a blood clot from a ruptured coronary artery atherosclerotic plaque. Other causes include spontaneous coronary artery dissection (SCAD), which most commonly occurs in women. ACS is usually treated in a cath lab with angioplasty and the placement of a stent to prop the vessel open.

stock market

Avertix Medical, known for its implantable heart attack detection devices, to go public with initial value of $195M

The healthcare technology company, previously known as Angel Medical Systems, is merging with BIOS Acquisition Corporation to form a new publicly traded company.

May 3, 2023
E-tattoo chest heart monitor designed by engineers with the University of Texas at Austin

A key step forward: Engineers take wearable ‘e-tattoo’ technology for heart disease to the next level

The new-look device, which captures ECG and seismocardiogram measurements at the same time, is completely wireless and runs on batteries that last up to 40 hours. 

May 2, 2023
Paul M. Ridker, MD, MPH, director of the Center for Cardiovascular Disease Prevention, and the Eugene Braunwald Professor of Medicine, cardiovascular medicine, Brigham and Women's Hospital, who presented the results of late-breaking study on residual inflammatory risk in contemporary statin treated patients. The study used an analyses of 31,197 patients in the PROMINENT, REDUCE-IT and STRENGTH trials. 

What new data can teach cardiologists about statin use and treating inflammation

"If we do not attack the inflammation, we just are not going to get the best outcomes for our patients," one researcher told Cardiovascular Business. 

May 1, 2023
Janet Wei at Cedars-Sinai Hospital explains INOCA and MINOCA at ACC 2023.

Understanding INOCA and MINOCA epidemiology

Janet Wei, MD, associate medical director of the Biomedical Imaging Research Institute, and co-director of the stress echocardiography lab at Cedars-Sinai Hospital, explains the current information on the INOCA and MINOCA.

April 26, 2023
Elderly patient doctor. Despite an expanded indication from the FDA and lower prices, patient access to these cholesterol-lowering medications remains a significant issue.

New details on the link between CVD and cancer, from a study of 27M patients

According to the large new study, published in JACC: CardioOncologyatherosclerotic CVD is associated with an especially high risk of cancer. 

April 18, 2023
#ACC23 #ACC #Heartflow

HeartFlow announces US launch of AI-powered solution for evaluating coronary arteries

The AI-powered tool gained FDA clearance back in October 2022. 

April 18, 2023
American Heart Association and Joint Commission launch new Comprehensive Heart Attack Center certification.

ACS and revascularization after TAVR: New data on a high-risk scenario

“It is vital to identify patients who are at a high risk for ACS after TAVR for potential treatment beforehand,” according a new analysis published in the American Journal of Cardiology.

April 17, 2023

Clopidogrel linked to better long-term outcomes than aspirin in PCI patients with and without diabetes

Clopidogrel is especially effective at limiting major adverse cardiovascular events among PCI patients with diabetes, researchers found. 

April 13, 2023

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Trimed Popup
Trimed Popup